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A Case of Hashimoto Encephalopathy Manifesting as Diffuse Extremity Weakness and Confusion
Cody Paiva DO MPH, Brinton Clark MD

Case Presentation
A 42-year-old female with a past medical history of schizoaffective
disorder recently discontinued on multiple psychiatric medications, stable
HIV, and hypothyroidism presented with a chief complaint of diffuse
extremity weakness and Parkinsonism-like symptoms.
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History of Present Illness
4-month history of jerking leg movements bilaterally
2-week history of ”feeling paralyzed” with difficulty ambulating
Recent long-term hospitalization at a psychiatric facility as a ward of
the state
Multiple changes to psychiatric medication regimen, including abrupt
discontinuation of clozapine and risperidone
Abrupt onset confusion at facility and decreased level of interaction at
facility prior to admission
Exam
T 98.8F, BP 114/66, P 73, RR 18, SpO2 94% on room air
Neck: thyroid without nodules or enlargement
Neuro: CN II-X intact. XI: 0/5 muscle strength on shoulder shrug or
head turn. Bilateral shoulder and forearm strength 1/5 bilaterally; hip
and thigh flexion/extension 0/5 bilaterally; sensation intact to bilateral
upper and lower extremities
Mental status: disoriented to time, place, situation. Oriented to person.

Lab
WBC, CSF
Glucose, CSF
Protein, CSF
Thyroglobulin Ab, Serum
Thyroid Peroxidase Ab, Serum
TSH, Serum

Value
3
64
82
910
>1200
1.36

Normal Limit
0-5
40-60
12-39
0.3-9
<4
0.33-4.70

Table 1: Pertinent lab values for the diagnosis of Hashimoto encephalopathy

A

B

• CSF fluid analysis: elevated protein, mildly elevated glucose
• Blood, CSF, urine cultures show no growth
• Continuous EEG: generalized slowing consistent with encephalopathy;
no epileptiform activity
• CSF negative for VDRL, HSV, VZV, EBV, CMV, fungal elements

DIAGNOSIS
• TSH can range from euthyroid to hypothyroid
• TPO Ab and thyroglobulin Ab are commonly significantly elevated
• CSF findings: elevated protein, lymphocytic infiltrate
• EEG: non-specific slowing suggestive of encephalopathy
• MRI: normal, some cases with focal hyperintensity

Conclusion
• Here we present a 42-year-old female with a rare case of Hashimoto
encephalopathy manifesting as confusion and weakness
• The most common clinical presentations for HE include cognitive
impairment, ataxia, and focal neurologic deficits
• This case demonstrates that presentation of a primary autoimmune
disorder can manifest despite normal TSH and unrevealing imaging
findings

Figure 1: A) Axial T2 FLAIR brain MRI in
this patient without acute abnormality, a
common finding in Hashimoto
encephalopathy. B) T2 FLAIR MRI brain
finding in another patient with HE showing
a focal area of hyperintensity in the right
frontal lobe.

• This patient responded to high dose prednisone for 2 weeks with a
prolonged taper and 4 days of IVIG with resolution of muscle weakness
and confusion

• Ativan challenge: 2mg lorazepam every 2 hours for 24 hours; if positive,
suggestive of neuroleptic catatonia. In this patient, this was negative
Treatment:
• Dexamethasone challenge resulted in improvement of muscle
weakness, confusion
• Prolonged prednisone course with months-long taper

Overview
• Hashimoto encephalopathy is a rare disorder affecting patients who are
commonly euthyroid, thought to be an immune complex inflammatory
response in the cerebral vasculature
• HE more commonly affected by women than men
• It is characterized by fluctuating neurologic symptoms, most commonly
behavior disturbances, confusion, and gait disturbances

MANAGEMENT
• High dose prednisone with a prolonged course and taper; often months
• >90% respond to corticosteroid therapy
• IVIG and plasmapheresis have shown improvement in some cases

Work Up and Hospital Course
Admission Labs and Work Up:
• See Table 1. Calcium 10.8, magnesium 1.6, lithium level 1.2. Other lab
values unremarkable
• Imaging studies without acute abnormality: CT head w/o contrast, MRI
brain, MRI cervical/thoracic/lumbar spine

Discussion
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